#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Synovial sarcoma recurrent Familial haemophagocytic lymphohistiocytosis Tourette's disorder Acute on chronic liver failure Cholangiocarcinoma IgA nephropathy Post transplant lymphoproliferative disorder Carcinoid tumour Chronic kidney disease Ovarian epithelial cancer KBG syndrome Congenital generalised lipodystrophy Ewing's sarcoma recurrent Thrombocytosis Usher's syndrome More trials…

    Learn about Rare Diseases

    Osteosarcoma – Trials in Disease Lymphatic malformation – Basic Information Cystic fibrosis lung – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency Short-bowel syndrome – Treatment Anaplastic thyroid cancer – Trials in Disease Progressive multifocal leukoencephalopathy Hypereosinophilic syndrome – Basic Information Antisynthetase syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ertapenem Sodium HYDROGEN Amsacrine Vigabatrin Birtamimab Danicamtiv Alnus Glutinosa Pollen Ly3454738 OLVEREMBATINIB Betahistine Dihydrochloride Vimseltinib Tamsulosin Hydrochloride Deupirfenidone Savolitinib Secale Cereale Balcinrenone Clofutriben Auto4 Bepirovirsen Cefepime Hydrochloride More therapies…

    Learn about Your Condition

    Seizure Skin candida Placenta praevia Thromboembolectomy Raynaud's phenomenon T-cell type acute leukaemia VEXAS syndrome Meningioma malignant Glomerulonephritis acute BK virus infection Bacteraemia Laparoscopic surgery Alveolar rhabdomyosarcoma Labour induction Lymphangiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Cabergoline for Pain and Fertility in Women with Endometriosis and Infertility

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Cabergoline
    Finland

  • Study on Renaparin for Improving Kidney Function in Transplant Patients with End-Stage Renal Disease from Deceased Donors

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Corline Heparin Conjugate
    Austria Germany

  • Study on the Effectiveness and Safety of Imetelstat for Patients with High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia After HMA Therapy Failure

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Chlorhexidine Dihydrochloride
    • Imetelstat Sodium
    • Diphenhydramine Hydrochloride
    France Germany

  • Study on Stopping Atorvastatin in Frail Patients Aged 70+ with Recent Ischemic Stroke or Transient Ischemic Attack

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Ischaemic stroke
    Investigated Drugs:
    • Atorvastatin
    The Netherlands

  • Study on Acetazolamide with Radiochemotherapy or Radioimmunotherapy for Patients with Small Cell Lung Cancer

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Acetazolamide
    France

  • Study on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Florbetaben (18F)
    • Flutemetamol (18F)
    Belgium Czechia Denmark Finland France Germany +5
Previous Page
1 … 890 891 892 893 894 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!